Tracking the next pandemic: Avian Flu Talk |
GlaxoSmithKline, CureVac to make COVID-19 vaccines |
Post Reply |
Author | |
bradlux
V.I.P. Member Joined: May 18 2020 Status: Offline Points: 2050 |
Post Options
Thanks(0)
Posted: February 06 2021 at 1:10pm |
Drugmaker GlaxoSmithKline (GSK) said Wednesday it will work with a German biopharmaceutical company to develop new vaccines targeting emerging variants of coronavirus amid concerns that some mutations are making it harder to combat COVID-19 GSK said it plans to invest $181 million US to support the research of the Tubingen, Germany-based CureVac, which is developing vaccines that use messenger RNA to attack the disease. GSK said it will also help make up to 100 million doses of the company’s existing COVID-19 vaccine candidate this year. https://worldabcnews.com/glaxosmithkline-curevac-to-make-covid-19-vaccines-aimed-at-new-variants/ |
|
Post Reply | |
Tweet
|
Forum Jump | Forum Permissions You cannot post new topics in this forum You cannot reply to topics in this forum You cannot delete your posts in this forum You cannot edit your posts in this forum You cannot create polls in this forum You can vote in polls in this forum |